</>Build with Tariff Intelligence|Programmatic access to tariff calculations and HS code classification.Explore Developer Resources →
2933.99.75.00/Lapatinib Ditosylate/Canada

Lapatinib Ditosylate from Canada

Lapatinib ditosylate is a dual tyrosine kinase inhibitor for HER2-positive breast cancer. The core quinazoline structure (aromatic heterocyclic with nitrogen) places it under HTS 2933.99.75.00 as a drug.

Duty Rate — Canada → United States

16.5%

Rate breakdown

9903.05.2910%Section 301 (forced labor) — additional 10% ad valorem on products of Canada
Calculate with your customs valueVerify classification with AI

Import Tips

• Declare as 'Lapatinib ditosylate monohydrate' if hydrated form per CoA

• Include bioequivalence data if generic import competing with originator

Lapatinib Ditosylate from Canada — Import Duty Rate | HTS 2933.99.75.00